- Petter Björquist, Chief Executive Officer, PhD, holds a PhD in Biology/Biochemistry from Gothenburg University. Ten years within AstraZeneca R&D in Cardiovascular Diseases, twelve years at Cellartis/Cellectis as VP Regenerative Medicine, responsible for e.g. the major collaboration with Novo Nordisk on development of a human embryonic stem cell derived beta cell treatment for diabetes
- Raimund Strehl, PhD, Chief Technology Officer, holds a degree in cell biology from the University of Regensburg. Academic background within cell culture development and tissue engineering. Industrial background in the field of human pluripotent stem cell development and application. Over ten years at Cellartis, heading product development and manufacturing in the role of Chief Technology Officer, responsible for collaborations with major pharmaceutical and biotech companies.
- Edvard Nordfors, Chief Financial Officer, holds a MBA in Business Administration from University of Gothenburg. He has before joining NovaHep, worked as CFO in both Sweden and the Netherlands. He has extensive international experience in financial management, M&A and investments from both large and small companies across several industries, including the Life Science industry.